Biblio

Export 3139 results:
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2016
G. Koch, Di Lorenzo, F., Del Olmo, M. Fernandez, Bonní, S., Ponzo, V., Caltagirone, C., Bozzali, M., and Martorana, A., “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
G. Grande, Cucumo, V., Cova, I., Ghiretti, R., Maggiore, L., Lacorte, E., Galimberti, D., Scarpini, E., Clerici, F., Pomati, S., Vanacore, N., and Mariani, C., “Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.”, J Alzheimers Dis, vol. 51, no. 1, pp. 57-67, 2016.
G. W. Arendash, “Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 753-71, 2016.
S. Baiardi, Capellari, S., Ladogana, A., Strumia, S., Santangelo, M., Pocchiari, M., and Parchi, P., “Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.”, J Alzheimers Dis, vol. 50, no. 2, pp. 465-76, 2016.
I. Beheshti, Olya, H. G. T., and Demirel, H., “Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1335-42, 2016.
B. Lebwohl, Luchsinger, J. A., Freedberg, D. E., Green, P. H. R., and Ludvigsson, J. F., “Risk of dementia in patients with celiac disease: a population-based cohort study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 179-85, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
C. T. Ambrose, “The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.”, J Alzheimers Dis, vol. 54, no. 1, pp. 31-43, 2016.
L. Szalárdy, Zádori, D., Klivenyi, P., and Vecsei, L., “The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.”, J Alzheimers Dis, vol. 53, no. 2, pp. 373-92, 2016.
Y. Noh, Seo, S. Won, Jeon, S., Lee, J. Min, Kim, J. Seung, Lee, J. - H., Kim, J. - H., Kim, G. Ha, Ye, B. Seok, Cho, H., Kim, H. Jin, Yoon, C. W., Choe, Y. Seong, Lee, K. - H., Weiner, M. W., and Na, D. L., “The Role of Cerebrovascular Disease in Amyloid Deposition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1015-1026, 2016.
H. - Y. Chen and Panegyres, P. K., “The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.”, J Alzheimers Dis, vol. 51, no. 2, pp. 515-23, 2016.
C. - L. Tsai, Pai, M. - C., Ukropec, J., and Ukropcová, B., “The Role of Physical Fitness in the Neurocognitive Performance of Task Switching in Older Persons with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 1, pp. 143-59, 2016.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., “Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
A. Palmeri, Mammana, L., Tropea, M. Rosaria, Gulisano, W., and Puzzo, D., “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
M. Sepe-Monti, Vanacore, N., Bartorelli, L., Tognetti, A., and Giubilei, F., “The Savvy Caregiver Program: A Probe Multicenter Randomized Controlled Pilot Trial in Caregivers of Patients Affected by Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1235-1246, 2016.
R. O'Caoimh, Timmons, S., and D Molloy, W., “Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.”, J Alzheimers Dis, vol. 51, no. 2, pp. 619-29, 2016.
M. Eugenia López, Turrero, A., Cuesta, P., López-Sanz, D., Bruña, R., Marcos, A., Gil, P., Yus, M., Barabash, A., Cabranes, J. Antonio, Maestú, F., and Fernández, A., “Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.”, J Alzheimers Dis, vol. 52, no. 1, pp. 133-43, 2016.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
J. L. Conde-Sala, Turró-Garriga, O., Portellano-Ortiz, C., Viñas-Diez, V., Gascón-Bayarri, J., and Reñé-Ramírez, R., “Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.”, J Alzheimers Dis, vol. 52, no. 3, pp. 999-1012, 2016.
M. - N. Vercambre, Okereke, O. I., Kawachi, I., Grodstein, F., and Kang, J. H., “Self-Reported Change in Quality of Life with Retirement and Later Cognitive Decline: Prospective Data from the Nurses' Health Study.”, J Alzheimers Dis, vol. 52, no. 3, pp. 887-98, 2016.
C. LoBue, Denney, D., Hynan, L. S., Rossetti, H. C., Lacritz, L. H., Hart, J., Womack, K. B., Woon, F. L., and C Cullum, M., “Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 727-36, 2016.
O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
A. M. V. Wennberg, Gustafson, D., Hagen, C. E., Roberts, R. O., Knopman, D., Jack, C., Petersen, R. C., and Mielke, M. M., “Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 2, pp. 573-81, 2016.

Pages